本研究首先探討O-tosyl amidoxime與3-dimethylaminopropenone在路易士酸FeCl3的催化下，進行[3+2]環加成反應得到4-acyl-2-substituted imidazole。但是 O-tosyl amidoxime具有只能合成烷基和拉電子性芳香環的限制，因而改為合成1,2,4-oxadiazol-5-one，與3-dimethylaminopropenone進行[3+2]環加成反應得到C2位為推電子性芳香環的4-acyl-2-substituted imidazole。
綜合兩種以O-tosyl amidoxime和1,2,4-oxadiazol-5-one合成的方法，與3-dimethylaminopropenone進行[3+2]環加成反應，成功合成各種不同官能基取代的4-acyl-2-alkyl/arylimidazole衍生物。

A [3+2] cycloaddition reaction of O-tosyl amidoxime and 3-dimethylamino-1-propenone derivatives under the catalysis of FeCl3 as Lewis acid to afford 4-acyl-2-alkylimidazoles has been studied. But O-tosyl amidoximes were limited to only alkyl and electron-withdrawing aryl substituents. Therefore, we developed another [3+2] cycloaddition reaction which used 1,2,4-oxadiazol-5-one derivatives as starting materials to react with 3-dimethylaminopropenone to obtain 4-acyl-2-substituted imidazoles with C2 electron-withdrawing aryl group.
Combine with the reactions of either O-tosyl amidoxime or 1,2,4-oxadiazol-5-one as the starting material, the [3+2] cycloaddition reaction with 3-dimethylamino-1-propenone can afford the corresponding 4-acyl-2-substituted imidazoles in good yields. We have succeeded to synthesize a variety of 4-acyl-2-alkyl/arylimidazole derivatives with different functional groups by this methodology.

1. K. Shalini, P. K. Sharma, N. Kumar. Der Chemica Sinica. 2010, 1, 36–47.
2. H. Debus. Annalen der Chemie und Pharmacie. 1858, 107, 199–208.
3. A. Arduengo III, F. Gentry Jr, P. Taverkere, H. Simmons III. US Patent 6,177,575, 2001. Chem. Abstr; 2001; 2001. p. 34.
4. M. Yamada, T. Yura, M. Morimoto, T. Harada, K. Yamada, Y. Honma, M. Kinoshita, M. Sugiura. J. Med. Chem. 1996, 39, 596–604.
5. J. P. Ferris, L. E. Orgel. J. Am. Chem. Soc. 1966, 88, 3829–3831.
6. J. P. Ferris, L. E. Orgel. J. Am. Chem. Soc. 1966, 88, 1074–1074.
7. Y. F. Shealy, C. A. Krauth, J. A. Montgomery. J. Org. Chem. 1962, 27, 2150–2154.
8. U. S. Mahajan, R. R. Godinde, P. N. Mandhare. Synth. Commun. 2011, 41, 2195–2199.
9. X. Wei, M. Zhao, Z. Du, X. Li. Org. Lett. 2011, 13, 4636–4639.
10. J. Li, M. John, L. Ackermann. Chem. Eur. J. 2014, 20, 5403–5408.
11. G. Kempter, J. Spindler, H. J. Fiebig, G. Sarodnick. Journal fr Praktische Chemie. 1971, 313, 977–985.
12. S. Ahmad, K. Ngu, D. W. Combs, S. C. Wu, D. S. Weinstein, W. Liu, B.-C. Chen, G. Chandrasena, C. R. Dorso, M. Kirby, K. S. Atwal. Bioorg. Med. Chem. Lett. 2004, 14, 177–180.
13. D. Carcache, I. Vranesic, J. Blanz, S. Desrayaud, M. Fendt, R. Glatthar. ACS Med. Chem. Lett. 2011, 2, 58–62.
14. J. Lessel. Arch. Pharm. 1993, 326, 383–389.
15. W. Xu, G. Wang, N. Sun, Y. Liu. Org. Lett. 2017, 19, 3307–3310.
16. J. O. Strelnikova, N. V. Rostovskii, G. L. Starova, A. F. Khlebnikov, M. S. Novikov. J. Org. Chem. 2018, 83, 11232–11244.
17. S. Kitamura, H. Fukushi, T. Miyawaki, M. Kawamura, Z.-i. Terashita, T. Naka. Chem. Pharm. Bull. 2001, 49, 268–277.
18. X. Yu, K. Chen, F. Yang, S. Zha, J. Zhu. Org. Lett. 2016, 18, 5412–5415.
19. K. Ohe, K. Okamoto, T. Shimbayashi. Synlett. 2014, 25, 1916–1920.
20. Y. Zhao, Y. Hu, X. Li, B. Wan. Organic and Biomolecular Chemistry. 2017, 15, 3413–3417.
21. S. Buscemi, N. Vivona, T. Caronna. J. Org. Chem. 1996, 61, 8397–8401.
22. K. Hemming. 5.04 - 1,2,4-Oxadiazoles. In: Katritzky, A. R., Ramsden, C. A., Scriven, E. F. V., Taylor, R. J. K. (eds). Comprehensive Heterocyclic Chemistry III. Elsevier: Oxford, 2008, pp 243–314.
23. C. C. Lin, T. H. Hsieh, P. Y. Liao, Z. Y. Liao, C. W. Chang, Y. C. Shih, W. H. Yeh, T. C. Chien. Org. Lett. 2014, 16, 892–895.
24. T.-C. Chien, C.-H. Wang, T.-H. Hsieh, C.-C. Lin, W.-H. Yeh, C.-A. Lin. Synlett. 2015, 26, 1823–1826.
25. T.-H. Hsieh, P.-Y. Liao, Y.-T. Liu, C.-H. Wang, C.-C. Lin, T.-C. Chien. J. Chin. Chem. Soc. 2018, 65, 325–330.
26. J. A. Hyatt. J. Org. Chem. 1981, 46, 3953–3955.
27. N. D. Heindel, M. C. Chun. Tetrahedron Lett. 1971, 12, 1439–1440.
28. J. J. Baldwin, M. E. Christy, G. H. Denny, C. N. Habecker, M. B. Freedman, P. A. Lyle, G. S. Ponticello, S. L. Varga, D. M. Gross, C. S. Sweet. J. Med. Chem. 1986, 29, 1065–1080.
29. N. Kudo, S. Furuta, M. Taniguchi, T. Endo, K. Sato. Chem. Pharm. Bull. 1999, 47, 857–868.
30. J.-M. Stutzmann, G. A. Bohme, A. Boireau, D. Damour, M. W. Debono, A. Genevois-Borella, A. Imperato, P. Jimonet, J. Pratt, J. C. R. Randle, Y. Ribeill, M. Vuilhorgne, S. Mignani. Bioorg. Med. Chem. Lett. 2000, 10, 1133–1137.
31. T. Canton, G. A. Böhme, A. Boireau, F. Bordier, S. Mignani, P. Jimonet, G. Jahn, M. Alavijeh, J. Stygall, S. Roberts, C. Brealey, M. Vuilhorgne, M.-W. Debono, S. Le Guern, M. Laville, D. Briet, M. Roux, J.-M. Stutzmann, J. Pratt. J. Pharmacol. Exp. Ther. 2001, 299, 314–322.
32. M. Vuilhorgne, J. Malpart, S. Mutti, S. Mignani. J. Heterocycl. Chem. 2003, 40, 159–162.
33. S. Liu, P. N. Premnath, J. K. Bolger, T. L. Perkins, L. O. Kirkland, G. Kontopidis, C. McInnes. J. Med. Chem. 2013, 56, 1573–1582.
34. R. C. Reid, M. K. Yau, R. Singh, J. K. Hamidon, J. Lim, M. J. Stoermer, D. P. Fairlie. J. Med. Chem. 2014, 57, 8459–8470.
35. Y. Yamamoto, H. Mizuno, T. Tsuritani, T. Mase. Tetrahedron Lett. 2009, 50, 5813–5815.
36. A. Tam, I. S. Armstrong, T. E. La Cruz. Org. Lett. 2013, 15, 3586–3589.
37. R. E. Bolton, S. J. Coote, H. Finch, A. Lowdon, N. Pegg, M. V. Vinader. Tetrahedron Lett. 1995, 36, 4471–4474.
38. X. Yu, K. Chen, Q. Wang, S. Guo, S. Zha, J. Zhu. Angew. Chem. Int. Ed. Engl. 2017, 56, 5222–5226.